Protective effect of agmatine on ischemia/reperfusion-induced renal injury in rats

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 3, 2008, Pages 223-230

  Sugiura, Takahiro ^a   Tsutsui, Hidenobu ^a,b   Takaoka, Masanori ^a   Kobuchi, Shuhei ^a   Hayashi, Kentaro ^a   Fujii, Toshihide ^a   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA OHTANI UNIVERSITY   (Japan)

Author keywords

Acute renal failure; Agmatine; Ischemia reperfusion; Norepinephrine; Renal sympathetic nerve activity

Indexed keywords

AGMATINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROSTIMULATION; ISCHEMIA; KIDNEY INJURY; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; REPERFUSION INJURY; SYMPATHETIC NERVE;

AGMATINE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; KIDNEY FAILURE, ACUTE; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SYMPATHETIC NERVOUS SYSTEM;

EID: 41349121223     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318161d758     Document Type: Article

References (32)

1. Tabor CW, Tabor H, Polyamines. Annu Rev Biochem. 1984;53:749-790.
2. Li G, Regunathan S, Barrow CJ, et al. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 1994;263:966-969.
3. Raasch W, Regunathan S, Li G, et al. Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci. 1995;56:2319-2330.
4. Sastre M, Regunathan S, Galea E, et al. Agmatine activity in rat brain: a metabolic pathway for the degradation of agmatine. J Neurochem. 1996;67:1761-1765.
5. Yamanaka H, Shiomi K, Kikuchi T. Agmatine as a potential index for freshness of common squid (Todarodes pacificus). J Food Sci. 1987;52:936-938.
6. Reis DJ, Regunathan S. Agmatine: a novel neurotransmitter? Adv Pharmacol. 1998;42:645-649.
7. Sastre M, Regunathan S, Reis DJ. Uptake of agmatine into rat brain synaptosomes: possible role of cation channels. J Neurochem. 1997;69:2421-2426.
8. Reis DJ, Regunathan S. Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci. 2000;21:187-193.
9. Baines AD. Nerves disorders of renal function. Clin Biochem. 1983;16:134-140.
10. Iaina A, Eliahou HE. The sympathetic nervous system in the pathogenesis of acute renal failure. Clin Exp Dial Apheresis. 1983;7:115-125.
11. Fujii T, Kurata H, Takaoka M, et al. The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure. Eur J Pharmacol. 2003;481:241-248.
12. Sun MK, Regunathan S, Reis DJ. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat. Clin Exp Hypertens. 1995;17:115-128.
13. 2-adrenoceptors. J Pharmacol Exp Ther. 2003;304:1063-1071.
14. Kim DJ, Kim DI, Lee SK, et al. Protective effect of agmatine on reperfusion model after transient cerebral ischemia: temporal evolution on perfusion MR imaging and histopathologic findings. Am J Neuroradiol. 2006;27:780-785.
15. Paxions G, Watson C. The rat brain. Academic Press; 1998.
16. Shokoji T, Nishiyama A, Fujisawa Y, et al. Renal sympathetic nerve responses to Tempol in spontaneously hypertensive rats. Hypertention. 2003;41:266-273.
17. Hayashi K, Matsumura Y, Yoshida Y, et al. The role of endogenous angiotensin II in antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs. J Cardiovasc Pharmacol. 1991;17:807-813.
18. Caramelo C, Espinosa G, Manzarbeitia F, et al. Role of endothelium-related mechanisms in the pathophysiology of renal ischemia/reperfusion in normal rabbits. Circ Res. 1996;79:1031-1038.
19. Moss NG. Renal function and renal afferent and efferent nerve activity. Am J Physiol. 1982;243:F425-F433.
20. G-nitro-l-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs. J Pharmacol Exp Ther. 1994;269:529-535.
21. Tadano K, Matsuo G, Hashimoto T, et al. Effects of FK409, a nitric oxide donor, on renal responses to renal nerve stimulation in anesthetized dogs. Eur J Pharmacol. 1998;341:191-199.
22. Cronin RE, Erickson AM, De Torrente A, et al. Norepinephrine-induced acute renal failure: a reversible ischemic model of acute renal failure. Kidney Int. 1978;14:187-190.
23. Conger JD, Robinette JB, Hammond WS. Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int. 1991;39:1087-1097.
24. Solomon HS, Hollenberg NK. Catecholamine release: mechanism of mercury-induced vascular smooth muscle contraction. Am J Physiol. 1975;229:8-12.
25. Solez K, Ideura T, Silvia CB, et al. Clonidine after renal ischemia to lessen acute renal failure and microvascular damage. Kidney Int. 1980;18:309-322.
26. Solez K, D'Agostini RJ, Stawowy L, et al. Beneficial effect of propranolol in a histologically appropriate model of postischemic acute renal failure. Am J Pathol. 1977;88:163-192.
27. Chevalier RL, Finn WF. Effects of propranolol on post-ischemic acute renal failure. Nephron. 1980;25:77-81.
28. Wang W, Falk SA, Jittikanont S, et al. Protective effect of renal denervation on normotensive endotoxemia-induced acute renal failure in mice. Am J Physiol. 2002;283:F583-F587.
29. Oliver JA, Pinto J, Sciacca RR, et al. Basal norepinephrine overflow into the renal vein: effect of renal nerve stimulation. Am J Physiol. 1980;239:F371-F377.
30. Piletz JE, Chikkala DN, Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther. 1995;272:581-587.
31. Schwartz D, Peterson OW, Mendonca M, et al. Agmatine affects glomerular filtration via a nitric oxide synthase-dependent mechanism. Am J Physiol. 1997;272:F597-F601.
32. Lortie MJ, Novotny WF, Peterson OW, et al. Agmatine, bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J Clin Invest. 1996;97:413-420.